Eosinophilic Esophagitis in India: Low Prevalence, Emerging Insights, and Therapeutic Frontiers
Eosinophilic esophagitis (EoE) is a clinicopathological disorder characterized by dense eosinophil infiltration of the esophageal mucosa-at least 15 eosinophils per high-power field-and symptoms such as heartburn, chest pain, and dysphagia. 1Because these symptoms overlap with those of functional esophageal disorders, the Rome IV criteria advocate ruling out EoE before labeling the patient as functional esophageal disorder. 2EoE was long underrecognized as most of the patients with gastroesophageal reflux disease (GERD)like symptoms are usually treated empirically with protonpump inhibitors (PPIs) without further evaluation. 2Once researchers appreciated that some patients with GERD-like symptoms and eosinophilic esophagitis did not respond to PPIs, it became evident that EoE is a distinct condition requiring targeted diagnosis and management.The worldwide epidemiology of EoE has shifted dramatically in the past two decades.Population-based studies suggested a pooled prevalence of roughly 22.7 per 100,000 and an annual incidence around 3.7 per 100,000. 3High-income countries have reported prevalence rising above 34 per 100,000 and incidence approaching 7.7 per 100,000 adults. 4Asia, once considered largely free of EoE, is now experiencing growing detection.A Japanese registry reported an incidence of 2.82 per 100,000 and prevalence of 10.68 per 100,000, whereas a meta-analysis documented an increase from 19.8 to 73 per 100,000 in the region between 2005 to 2009 and 2015 to 2019. 5 These figures illustrate that EoE is not solely a Western disease and that improved awareness and surveillance can reveal cases that previously went undiagnosed.In India, however, published data remain scarce, prompting investigators to assess how frequently EoE occurs among patients with reflux-like symptoms. 6,7
Read more